Summary & Overview
CPT 00920: Anesthesia for Male Genital Procedures, NOS
Headline: CPT 00920: Anesthesia for Male Genital Procedures, NOS
Lead: CPT 00920 denotes anesthetic services for procedures on male genitalia when no more specific anesthesia code applies. It is relevant across outpatient hospital settings and by anesthesiology teams managing perioperative care for a range of genitourinary interventions.
What this code represents and why it matters nationally: CPT 00920 captures anesthesia delivery for male genital procedures that lack a dedicated anesthesia code. Nationally, accurate use of this code affects billing consistency, procedural reporting, and resource tracking for anesthesiology services in ambulatory surgical environments.
Key payers covered: The analysis covers major commercial payers including Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare, providing a broad view of payer recognition and coverage considerations for anesthesiology billing in outpatient hospitals.
Overview of what readers will learn: Readers will find a concise explanation of the code’s clinical and billing scope, comparisons to adjacent anesthesia codes for related male genital procedures, common clinical contexts that map to the code, and practical notes on site of service classification. Where input data is incomplete, the publication flags missing metadata. The content is intended to support coding accuracy, payer communications, and administrative clarity for anesthesia teams and billing staff.
CPT Code Overview
CPT 00920 describes anesthesia for procedures on male genitalia, not otherwise specified. This code is used for anesthetic management during surgical or procedural interventions on the male genital organs when a more specific male genitalia anesthesia code does not apply.
Service type: Anesthesiology
Typical site of service: Outpatient Hospital (POS 22)
Clinical & Coding Specifications
Clinical Context
A middle-aged male presents to an outpatient hospital surgical suite for a procedure on the external male genitalia (for example, circumcision for persistent phimosis or surgical drainage/repair for balanitis-related complications). Pre-procedure evaluation by anesthesia is completed in the pre-op area, including assessment of airway, medical history, and baseline vital signs. Anesthesia is administered in the operating room or procedure room. Monitored anesthesia care or regional/general anesthesia may be provided depending on procedure complexity and patient status. After the procedure, the patient is recovered in the same outpatient hospital setting and discharged when recovery criteria are met. Documentation includes the anesthetic technique, agents used, monitoring, ASA physical status, and any intraoperative events.
Coding Specifications
-
Modifiers
-
QS: Monitored anesthesia care service — Use when monitored anesthesia care is provided for the procedure on male genitalia and documentation supports MAC rather than general or regional anesthesia. -
P1: A normal healthy patient — Use to indicate the patient’s ASA physical status is I when reported by the anesthesia provider. -
Provider Taxonomies
-
207L00000X: Anesthesiology — Physicians specialized in anesthesiology who provide perioperative anesthesia care. -
207LA0401X: Anesthesiology Assistant — Certified anesthesiology assistants who work under anesthesiologist supervision to deliver anesthesia services. -
207LC0200X: Critical Care Medicine (Anesthesiology) — Anesthesiologists with critical care training who may manage higher-acuity perioperative or peri-procedural patients.
Related Diagnoses
N47.1— Phimosis
Clinical relevance: Phimosis can necessitate surgical intervention on the foreskin or glans, requiring anesthesia services appropriate for external male genital procedures.
N47.2— Paraphimosis
Clinical relevance: Paraphimosis is an acute condition that may require reduction or surgical management under anesthesia to relieve constriction and restore normal anatomy.
N48.1— Balanitis
Clinical relevance: Inflammatory conditions of the glans can lead to procedures such as debridement or circumcision, where anesthesia for male genitalia procedures is indicated.
N40.1— Benign prostatic hyperplasia with lower urinary tract symptoms
Clinical relevance: While primarily a prostatic condition, associated urologic procedures in the male genital/urinary region may involve anesthesia planning that falls under male genitalia anesthesia codes in certain workflows.
N49.0— Inflammatory disorders of the penis
Clinical relevance: Inflammatory penile disorders can require surgical intervention on external genitalia, necessitating anesthesia services described by the primary CPT code.
Related CPT Codes
00922— Anesthesia for procedures on male genitalia sperm duct surgery
Explanation: Used for anesthesia when the surgical procedure involves the spermatic duct structures; may be used as an alternative when the operative site and complexity involve sperm duct surgery rather than more distal genital procedures.
00918— Anesthesia for stone removal
Explanation: Pertains to anesthesia for removal of genitourinary stones; related by anatomical region in urologic workflows but distinct from standard external genital procedures; may be an alternative when stone removal is the primary procedure.
00921— Anesthesia for procedures on male genitalia, vasectomy
Explanation: Specific for vasectomy-related anesthesia; used when the primary procedure is vasectomy. 00921 may be selected instead of 00920 when the documented procedure is vasectomy. These codes can be alternatives depending on the exact surgical procedure performed.
National Reimbursement Benchmarks
National commercial mean rates for CPT 00920 show a marked difference between Medicare and the average commercial cohort represented by BUCA (Blue Cross/United Commercial Average). Medicare’s mean is not provided in the input, while BUCA’s mean rate is $134.69, indicating that commercial averages are substantially higher than Medicare would typically be for similar services.
Rate dispersion (P75 minus P25) varies notably across payers. Aetna shows the widest spread (P75 $302.00 minus P25 $42.33 = $259.67), followed by Cigna (spread $173.42) and BUCA (spread $130.50). UnitedHealth Group is the tightest (spread $25.47), with Blue Cross Blue Shield also relatively tight (spread $116.00) compared with the widest payers. The table and chart below present the full breakdown.
State Benchmarks
State: AK1 / 50
Alaska Benchmarks
Alaska displays a wide spread in reimbursement rates for CPT code 00920, with Blue Cross Blue Shield's 75th percentile ($268.67) notably higher than UnitedHealth Group's 25th percentile ($72.00). The difference between the highest and lowest 25th and 75th percentiles among payers highlights significant variability in payment levels across the state. This rate spread (P75 minus P25) is especially pronounced for Blue Cross Blue Shield, where the gap is $87.00, and for BUCA, where it is $88.83.
Compared to national averages, Alaska's mean rates for most payers are higher, except for Cigna and UnitedHealth Group, which fall below their respective national benchmarks. The table and chart below present the full breakdown of payer-specific reimbursement rates in Alaska, illustrating these disparities.
Key Insights for Alaska
- Blue Cross Blue Shield offers the highest mean reimbursement rate for CPT 00920 in Alaska at $220.98, while UnitedHealth Group is the lowest at $75.12.
- Cigna's mean rate in Alaska ($89.33) is significantly below its national average ($197.79), indicating a notable deviation.
- The rate spread among payers in Alaska is substantial, with BCBS's 75th percentile ($268.67) far exceeding the lowest 25th percentiles, highlighting wide variability.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.